Pfizer Says It Applied for Japan Government’s Approval for Oral COVID-19 Drug

A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration taken on Sept. 29, 2021. Dado Ruvic/Reuters

TOKYO—U.S. drugmaker Pfizer Inc. said on Friday it has applied for Japanese government approval for its oral COVID-19 treatment.

The application is based on global Phase II/III trials that Japan was part of, Pfizer said in a statement.